CRISPR-Cas9 targeted-knockout human colorectal cancer cell PPP1R1C gene and specific sgRNA thereof
A colorectal cancer cell, specific technology, applied in the field of gRNA, can solve the problem that the molecular mechanism of colorectal cancer is not yet clear
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] 1. Using CRISPR / Cas9 technology to construct a knockout PPP1R1C plasmid
[0045] 1.1 sgRNA oligonucleotide chain synthesis
[0046] Using the CRISPR online design tool (http: / / crispr.mit.edu / ) according to the scoring system, a 20bp sgRNA was designed on the third exon of PPP1R1C, and no non-specific genes were verified by BLAST. ACCG was added to the 5' end of the coding strand template, and AAAC was added to the 3' end of the non-coding strand template to complement the cohesive ends formed after digestion with BsmBI, and a pair of CRISPR oligonucleotide chains were designed, as shown in Table 1.
[0047] Table 1 PPP1R1C targeting site and sgRNA oligonucleotide sequence list
[0048]
[0049] 1.2 Vector construction
[0050] 1.2.1 Use BsmBI to digest 2 μg of Lenti-CRISPRv2 plasmid (purchased from Addgene), 2h, 37°C:
[0051] enzyme digestion system
[0052] 2μg (2μl)
Lenti-CRISPRv2
1μl
BsmBI (NEB)
5μl
10X Cutsmart
42μl ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com